<p>直覺外科（NASDAQ:ISRG - 獲取免費報告）於週四公佈了其財報。該醫療設備供應商報告本季度每股收益為 2.53 美元，超出分析師一致預期的 2.25 美元，超出幅度為 0.28 美元，FiscalAI 報道。直覺外科的淨利潤率為 28.58%，股本回報率為 15.08%。該公司本季度的收入為 28.7 億美元，而分析師的預期為 27.2 億美元。</p>
<p>獲取 <strong>Intuitive Surgical</strong> 的提醒：</p>
<h2>直覺外科股票上漲 0.3%</h2>
<ul>
<li>超越生物技術——3 只適合成長型投資者的醫療股</li>
</ul>
<p>直覺外科的股票在週四交易中上漲了 1.63 美元，達到 525.32 美元。該公司交易了 2,167,893 股，較其平均交易量 2,008,178 股有所增加。直覺外科的 52 周低點為 425.00 美元，52 周高點為 616.00 美元。該公司的 50 日移動平均價格為 563.63 美元，200 日移動平均價格為 511.76 美元。該股票的市值為 1883.2 億美元，市盈率為 69.49，市盈增長比率為 4.28，貝塔值為 1.67。</p>
<h2>直覺外科內部活動</h2>
<p>在相關消息中，執行副總裁亨利·L·查爾頓於 11 月 12 日（星期三）出售了 13,731 股公司的股票。股票以 580.00 美元的平均價格出售，總交易額為 7,963,980.00 美元。交易後，該執行副總裁持有 3,056 股公司的股票，價值約為 1,772,480 美元。這代表其持股比例減少了 81.80%。該出售在向 SEC 的備案中披露，相關信息可在 SEC 網站上查閲。此外，首席執行官大衞·J·羅薩於 10 月 24 日（星期五）出售了 24,500 股股票，股票以 547.55 美元的平均價格出售，總價值為 13,414,975.00 美元。交易後，首席執行官在公司中持有 234,256 股，價值為 128,266,872.80 美元。此交易代表其持股比例減少了 9.47%。有關此出售的更多細節可在官方 SEC 披露中找到。在過去 90 天內，內部人士共出售了 114,007 股公司股票，價值為 63,533,844 美元。內部人士持有該股票的比例為 0.70%。</p>
<h2>機構投資者對直覺外科的看法</h2>
<ul>
<li>2 只醫療股可能因財報獲得大幅提振</li>
</ul>
<p>一些機構投資者最近增加或減少了對該公司的持股。Riggs Asset Managment Co. Inc.在第二季度將其在直覺外科的持股增加了 84.2%。Riggs Asset Managment Co. Inc.目前持有 70 股該醫療設備供應商的股票，價值 38,000 美元，此前在上個季度又購買了 32 股。JPL Wealth Management LLC 在第三季度購買了直覺外科的新頭寸，價值約為 45,000 美元。Wealth Watch Advisors INC 在第三季度獲得了直覺外科的新頭寸，價值約為 52,000 美元。Triumph Capital Management 在第三季度購買了直覺外科的新股份，價值約為 54,000 美元。最後，Measured Wealth Private Client Group LLC 在第三季度獲得了直覺外科的股份，價值 70,000 美元。對沖基金和其他機構投資者持有該公司 83.64% 的股票。</p>
<h2>直覺外科新聞摘要</h2>
<p>以下是本週影響直覺外科的主要新聞：</p>
<ul>
<li>積極情緒：美國銀行啓動覆蓋，給予買入評級，為投資者提供了新的、可信的買方背書，可能提升近期對該股票的需求。直覺外科（ISRG）獲得美國銀行證券的買入評級</li>
<li>積極情緒：市場輪動進入醫療科技，樂觀的行業論點突顯 ISRG 的經常性收入模式和手術增長，支持多年的增長案例和分析師的目標價格高於當前股價。超越生物技術——3 只適合成長型投資者的醫療股（直覺外科部分）</li>
<li>積極情緒：長期樂觀分析認為，ISRG 的機器人驅動增長和刀片與刀柄的經常性收入在多年的時間範圍內創造了吸引人的上行空間，強化了成長投資者的買入和持有敍事。直覺外科在五年後會在哪裏？</li>
<li>中性情緒：多份財報預覽和分析師筆記（TipRanks、MSN、Zacks）強調第四季度的業績和指引是下一個催化劑；這些預覽突出了投資者應關注的指標（手術量、系統部署、經常性消耗品增長）。直覺外科（ISRG）即將公佈第四季度財報。以下是預期</li>
<li>中性情緒：關於每週失業救濟申請的宏觀頭條消息喜憂參半，可能影響廣泛市場的風險偏好（從而影響醫療科技的倍數擴張/收縮），但並不會直接改變 ISRG 的基本面。失業救濟申請保持在 20 萬以上，第三季度 GDP 增長至 4.4%</li>
<li>消極情緒：短期技術疲軟：覆蓋筆記和市場報告指出，該股票已延續了虧損趨勢，這可能觸發止損和短期賣壓，即使基本面保持不變。直覺外科連續七個交易日虧損</li>
<li>消極情緒：估值爭論：評論質疑 ISRG 在近期價格表現疲軟後是否被高估，可能使一些投資者在更清晰的財報/指引證據出現之前保持觀望。評估直覺外科（ISRG）股票在近期價格表現疲軟後是否顯得被高估</li>
</ul>
<h2>華爾街分析師的看法</h2>
<ul>
<li>1.34 億美元的內部交易：這可能對 KMI、ISRG 和 QS 意味着什麼</li>
</ul>
<p>最近，一些研究分析師對該公司發佈了報告。Weiss Ratings 在 12 月 29 日的報告中重新發布了對 Intuitive Surgical 股票的 “持有（c+）” 評級。高盛集團在 1 月 9 日的研究報告中重新發布了 “買入” 評級，並對 Intuitive Surgical 股票設定了 714.00 美元的目標價。Raymond James Financial 在 10 月 22 日的研究報告中對 Intuitive Surgical 股票設定了 603.00 美元的目標價，並給予該股票 “跑贏大盤” 的評級。瑞銀集團在 1 月 15 日的研究報告中重申了對 Intuitive Surgical 股票的 “中性” 評級。最後，Truist Financial 在 12 月 18 日的研究報告中將 Intuitive Surgical 股票的目標價從 620.00 美元上調至 650.00 美元，並給予該股票 “買入” 評級。有兩位研究分析師給予該股票 “強烈買入” 評級，十六位給予 “買入” 評級，八位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat 的數據，該股票的共識評級為 “適度買入”，平均目標價為 622.17 美元。</p>
<p><strong>查看我們對 Intuitive Surgical 的最新分析</strong></p>
<h2>Intuitive Surgical 公司簡介</h2>
<p>(獲取免費報告)</p>
<p>Intuitive Surgical 成立於 1995 年，總部位於加利福尼亞州陽光谷，是一家專注於設計、製造和服務機器人輔助手術系統的醫療技術公司。該公司以其達芬奇手術系統而聞名，該系統通過將外科醫生的手部動作轉化為患者體內小型儀器的更精細、縮放的運動，從而實現微創手術。Intuitive 的業務主要集中在向醫院和手術中心提供系統、儀器及相關技術，旨在提高手術室的精確度、可視化和控制能力。</p>
<p>除了其核心手術平台外，Intuitive 還銷售一系列可重複使用和一次性使用的儀器、配件和專有軟件，併為客户提供培訓、服務和臨牀支持。</p>
<h2>推薦故事</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Intuitive Surgical</li>
<li>特朗普的 AI 秘密：比 Nvidia 快 100 倍</li>
<li>1933 年的退款：特朗普的重置可能創造即時財富</li>
<li>新的黃金價格目標</li>
<li>沒有人告訴你的 100 萬億美元 AI 故事</li>
<li>特朗普做了什麼？？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在 Intuitive Surgical 嗎？</h2>
<p>在考慮投資 Intuitive Surgical 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Intuitive Surgical 並不在名單上。</p>
<p>雖然 Intuitive Surgical 目前在分析師中獲得 “適度買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

標普健康醫療設備 ETF - SPDR

ISUL

直覺外科

美國醫藥設備 ETF - iShares

<p>直覺外科 (NASDAQ:ISRG) 報告每股收益為 2.53 美元，超出預期的 2.25 美元，季度收入為 28.7 億美元，超過預期的 27.2 億美元。該公司實現淨利潤率為 28.58%，股本回報率為 15.08%。公告發布後，股價上漲 0.3%，至 525.32 美元。內部交易中高管進行了大量出售，機構投資者持有 83.64% 的股份。分析師們保持樂觀，摩根大通首次覆蓋給予買入評級，強調醫療科技領域的增長潛力</p>

<p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) announced its earnings results on Thursday. The medical equipment provider reported $2.53 EPS for the quarter, beating analysts' consensus estimates of $2.25 by $0.28, FiscalAI reports. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business had revenue of $2.87 billion during the quarter, compared to analysts' expectations of $2.72 billion.</p>
<div class="lb-trans"><p>直覺外科（NASDAQ:ISRG - 獲取免費報告）於週四公佈了其財報。該醫療設備供應商報告本季度每股收益為 2.53 美元，超出分析師一致預期的 2.25 美元，超出幅度為 0.28 美元，FiscalAI 報道。直覺外科的淨利潤率為 28.58%，股本回報率為 15.08%。該公司本季度的收入為 28.7 億美元，而分析師的預期為 27.2 億美元。</p>
</div><p>Get <strong>Intuitive Surgical</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Intuitive Surgical</strong> 的提醒：</p>
</div><h2>Intuitive Surgical Stock Up 0.3%</h2>
<div class="lb-trans"><h2>直覺外科股票上漲 0.3%</h2>
</div><ul>
<li>Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>超越生物技術——3 只適合成長型投資者的醫療股</li>
</ul>
</div><p>Shares of Intuitive Surgical stock traded up $1.63 during trading on Thursday, hitting $525.32. 2,167,893 shares of the company were exchanged, compared to its average volume of 2,008,178. Intuitive Surgical has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The firm has a 50 day moving average price of $563.63 and a 200 day moving average price of $511.76. The stock has a market capitalization of $188.32 billion, a price-to-earnings ratio of 69.49, a P/E/G ratio of 4.28 and a beta of 1.67.</p>
<div class="lb-trans"><p>直覺外科的股票在週四交易中上漲了 1.63 美元，達到 525.32 美元。該公司交易了 2,167,893 股，較其平均交易量 2,008,178 股有所增加。直覺外科的 52 周低點為 425.00 美元，52 周高點為 616.00 美元。該公司的 50 日移動平均價格為 563.63 美元，200 日移動平均價格為 511.76 美元。該股票的市值為 1883.2 億美元，市盈率為 69.49，市盈增長比率為 4.28，貝塔值為 1.67。</p>
</div><h2>Insider Activity at Intuitive Surgical</h2>
<div class="lb-trans"><h2>直覺外科內部活動</h2>
</div><p>In related news, EVP Henry L. Charlton sold 13,731 shares of the company's stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the transaction, the executive vice president owned 3,056 shares of the company's stock, valued at approximately $1,772,480. This represents a 81.80% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO David J. Rosa sold 24,500 shares of the stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $547.55, for a total value of $13,414,975.00. Following the transaction, the chief executive officer owned 234,256 shares in the company, valued at $128,266,872.80. This trade represents a 9.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 114,007 shares of company stock valued at $63,533,844 in the last ninety days. 0.70% of the stock is owned by insiders.</p>
<div class="lb-trans"><p>在相關消息中，執行副總裁亨利·L·查爾頓於 11 月 12 日（星期三）出售了 13,731 股公司的股票。股票以 580.00 美元的平均價格出售，總交易額為 7,963,980.00 美元。交易後，該執行副總裁持有 3,056 股公司的股票，價值約為 1,772,480 美元。這代表其持股比例減少了 81.80%。該出售在向 SEC 的備案中披露，相關信息可在 SEC 網站上查閲。此外，首席執行官大衞·J·羅薩於 10 月 24 日（星期五）出售了 24,500 股股票，股票以 547.55 美元的平均價格出售，總價值為 13,414,975.00 美元。交易後，首席執行官在公司中持有 234,256 股，價值為 128,266,872.80 美元。此交易代表其持股比例減少了 9.47%。有關此出售的更多細節可在官方 SEC 披露中找到。在過去 90 天內，內部人士共出售了 114,007 股公司股票，價值為 63,533,844 美元。內部人士持有該股票的比例為 0.70%。</p>
</div><h2>Institutional Investors Weigh In On Intuitive Surgical</h2>
<div class="lb-trans"><h2>機構投資者對直覺外科的看法</h2>
</div><ul>
<li>2 Healthcare Names That Could Get a Big Boost From Earnings</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只醫療股可能因財報獲得大幅提振</li>
</ul>
</div><p>A number of institutional investors have recently added to or reduced their stakes in the company. Riggs Asset Managment Co. Inc. lifted its stake in shares of Intuitive Surgical by 84.2% in the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider's stock valued at $38,000 after purchasing an additional 32 shares in the last quarter. JPL Wealth Management LLC purchased a new position in Intuitive Surgical in the third quarter valued at approximately $45,000. Wealth Watch Advisors INC acquired a new position in Intuitive Surgical during the third quarter valued at approximately $52,000. Triumph Capital Management purchased a new stake in Intuitive Surgical during the third quarter worth approximately $54,000. Finally, Measured Wealth Private Client Group LLC acquired a new stake in shares of Intuitive Surgical in the third quarter worth $70,000. Hedge funds and other institutional investors own 83.64% of the company's stock.</p>
<div class="lb-trans"><p>一些機構投資者最近增加或減少了對該公司的持股。Riggs Asset Managment Co. Inc.在第二季度將其在直覺外科的持股增加了 84.2%。Riggs Asset Managment Co. Inc.目前持有 70 股該醫療設備供應商的股票，價值 38,000 美元，此前在上個季度又購買了 32 股。JPL Wealth Management LLC 在第三季度購買了直覺外科的新頭寸，價值約為 45,000 美元。Wealth Watch Advisors INC 在第三季度獲得了直覺外科的新頭寸，價值約為 52,000 美元。Triumph Capital Management 在第三季度購買了直覺外科的新股份，價值約為 54,000 美元。最後，Measured Wealth Private Client Group LLC 在第三季度獲得了直覺外科的股份，價值 70,000 美元。對沖基金和其他機構投資者持有該公司 83.64% 的股票。</p>
</div><h2>Intuitive Surgical News Summary</h2>
<div class="lb-trans"><h2>直覺外科新聞摘要</h2>
</div><p>Here are the key news stories impacting Intuitive Surgical this week:</p>
<div class="lb-trans"><p>以下是本週影響直覺外科的主要新聞：</p>
</div><ul>
<li>Positive Sentiment: Bank of America initiated coverage with a Buy, giving investors a fresh, reputable buy-side endorsement that can lift near-term demand for the shares. Intuitive Surgical (ISRG) Receives a Buy from Bank of America Securities</li>
<li>Positive Sentiment: Market rotation into medtech and a bullish sector thesis highlight ISRG’s recurring-revenue model and procedure growth, supporting a multi-year growth case and analyst price targets above the current share price. Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors (Intuitive Surgical section)</li>
<li>Positive Sentiment: Long-term bullish analysis argues ISRG’s robotics-led growth and razor‑and‑blade recurring revenue create attractive upside over a multi-year horizon, reinforcing buy-and-hold narratives for growth investors. Where Will Intuitive Surgical Be in 5 Years?</li>
<li>Neutral Sentiment: Multiple earnings previews and analyst notes (TipRanks, MSN, Zacks) emphasize Q4 results and guidance as the next catalyst; these previews highlight metrics investors should watch (procedure volumes, system placements, recurring consumable growth). Intuitive Surgical (ISRG) Is About to Report Q4 Earnings. Here Is What to Expect</li>
<li>Neutral Sentiment: Macro headlines on weekly jobless claims are mixed and may influence broad market risk appetite (and thus medtech multiple expansion/contraction), but they don’t directly alter ISRG’s fundamentals. Jobless Claims Stay Low at +200K, Q3 GDP Up to +4.4%</li>
<li>Negative Sentiment: Short-term technical weakness: coverage notes and market reports point out the stock has been extending a losing streak, which can trigger stop-losses and short-term selling pressure even if fundamentals remain intact. Intuitive Surgical continues losses for seven straight sessions</li>
<li>Negative Sentiment: Valuation debate: commentary questioning whether ISRG is overvalued after recent weak price performance could keep some investors sidelined until clearer earnings/guidance evidence appears. Assessing Whether Intuitive Surgical (ISRG) Shares Look Overvalued After Recent Weak Price Performance</li>
</ul>
<div class="lb-trans"><ul>
<li>積極情緒：美國銀行啓動覆蓋，給予買入評級，為投資者提供了新的、可信的買方背書，可能提升近期對該股票的需求。直覺外科（ISRG）獲得美國銀行證券的買入評級</li>
<li>積極情緒：市場輪動進入醫療科技，樂觀的行業論點突顯 ISRG 的經常性收入模式和手術增長，支持多年的增長案例和分析師的目標價格高於當前股價。超越生物技術——3 只適合成長型投資者的醫療股（直覺外科部分）</li>
<li>積極情緒：長期樂觀分析認為，ISRG 的機器人驅動增長和刀片與刀柄的經常性收入在多年的時間範圍內創造了吸引人的上行空間，強化了成長投資者的買入和持有敍事。直覺外科在五年後會在哪裏？</li>
<li>中性情緒：多份財報預覽和分析師筆記（TipRanks、MSN、Zacks）強調第四季度的業績和指引是下一個催化劑；這些預覽突出了投資者應關注的指標（手術量、系統部署、經常性消耗品增長）。直覺外科（ISRG）即將公佈第四季度財報。以下是預期</li>
<li>中性情緒：關於每週失業救濟申請的宏觀頭條消息喜憂參半，可能影響廣泛市場的風險偏好（從而影響醫療科技的倍數擴張/收縮），但並不會直接改變 ISRG 的基本面。失業救濟申請保持在 20 萬以上，第三季度 GDP 增長至 4.4%</li>
<li>消極情緒：短期技術疲軟：覆蓋筆記和市場報告指出，該股票已延續了虧損趨勢，這可能觸發止損和短期賣壓，即使基本面保持不變。直覺外科連續七個交易日虧損</li>
<li>消極情緒：估值爭論：評論質疑 ISRG 在近期價格表現疲軟後是否被高估，可能使一些投資者在更清晰的財報/指引證據出現之前保持觀望。評估直覺外科（ISRG）股票在近期價格表現疲軟後是否顯得被高估</li>
</ul>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師的看法</h2>
</div><ul>
<li>$134M in Insider Moves: What It Might Mean for KMI, ISRG and QS</li>
</ul>
<div class="lb-trans"><ul>
<li>1.34 億美元的內部交易：這可能對 KMI、ISRG 和 QS 意味着什麼</li>
</ul>
</div><p>A number of research analysts have recently issued reports on the company. Weiss Ratings reissued a &#34;hold (c+)&#34; rating on shares of Intuitive Surgical in a report on Monday, December 29th. The Goldman Sachs Group reissued a &#34;buy&#34; rating and issued a $714.00 price objective on shares of Intuitive Surgical in a research note on Friday, January 9th. Raymond James Financial set a $603.00 price objective on shares of Intuitive Surgical and gave the stock an &#34;outperform&#34; rating in a research report on Wednesday, October 22nd. UBS Group restated a &#34;neutral&#34; rating on shares of Intuitive Surgical in a research note on Thursday, January 15th. Finally, Truist Financial boosted their price target on shares of Intuitive Surgical from $620.00 to $650.00 and gave the stock a &#34;buy&#34; rating in a research note on Thursday, December 18th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $622.17.</p>
<div class="lb-trans"><p>最近，一些研究分析師對該公司發佈了報告。Weiss Ratings 在 12 月 29 日的報告中重新發布了對 Intuitive Surgical 股票的 “持有（c+）” 評級。高盛集團在 1 月 9 日的研究報告中重新發布了 “買入” 評級，並對 Intuitive Surgical 股票設定了 714.00 美元的目標價。Raymond James Financial 在 10 月 22 日的研究報告中對 Intuitive Surgical 股票設定了 603.00 美元的目標價，並給予該股票 “跑贏大盤” 的評級。瑞銀集團在 1 月 15 日的研究報告中重申了對 Intuitive Surgical 股票的 “中性” 評級。最後，Truist Financial 在 12 月 18 日的研究報告中將 Intuitive Surgical 股票的目標價從 620.00 美元上調至 650.00 美元，並給予該股票 “買入” 評級。有兩位研究分析師給予該股票 “強烈買入” 評級，十六位給予 “買入” 評級，八位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat 的數據，該股票的共識評級為 “適度買入”，平均目標價為 622.17 美元。</p>
</div><p><strong>View Our Latest Analysis on Intuitive Surgical</strong></p>
<div class="lb-trans"><p><strong>查看我們對 Intuitive Surgical 的最新分析</strong></p>
</div><h2>Intuitive Surgical Company Profile</h2>
<div class="lb-trans"><h2>Intuitive Surgical 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(獲取免費報告)</p>
</div><p>Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.</p>
<div class="lb-trans"><p>Intuitive Surgical 成立於 1995 年，總部位於加利福尼亞州陽光谷，是一家專注於設計、製造和服務機器人輔助手術系統的醫療技術公司。該公司以其達芬奇手術系統而聞名，該系統通過將外科醫生的手部動作轉化為患者體內小型儀器的更精細、縮放的運動，從而實現微創手術。Intuitive 的業務主要集中在向醫院和手術中心提供系統、儀器及相關技術，旨在提高手術室的精確度、可視化和控制能力。</p>
</div><p>In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.</p>
<div class="lb-trans"><p>除了其核心手術平台外，Intuitive 還銷售一系列可重複使用和一次性使用的儀器、配件和專有軟件，併為客户提供培訓、服務和臨牀支持。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than Intuitive Surgical</li>
<li>Trump’s AI Secret: 100X Faster Than Nvidia</li>
<li>Refund From 1933: Trump’s Reset May Create Instant Wealth</li>
<li>New gold price target</li>
<li>The $100 Trillion AI Story No One Is Telling You</li>
<li>Trump Did WHAT??</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Intuitive Surgical</li>
<li>特朗普的 AI 秘密：比 Nvidia 快 100 倍</li>
<li>1933 年的退款：特朗普的重置可能創造即時財富</li>
<li>新的黃金價格目標</li>
<li>沒有人告訴你的 100 萬億美元 AI 故事</li>
<li>特朗普做了什麼？？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=ISRG"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Intuitive Surgical Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 Intuitive Surgical 嗎？</h2>
</div><p>Before you consider Intuitive Surgical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮投資 Intuitive Surgical 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Intuitive Surgical 並不在名單上。</p>
</div><p>While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Intuitive Surgical 目前在分析師中獲得 “適度買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

直覺外科（NASDAQ 代碼：ISRG）公佈了財報結果